Navigation Links
MEI Pharma Announces Pricing of Public Offering of Common Stock
Date:10/25/2013

the acquisition of PWT143, a highly selective PI3-kinase delta inhibitor. For more information, go to www.meipharma.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.<
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 ... please scroll to bottom . Investor-Edge has ... MYL ), Salix Pharmaceuticals Ltd (NASDAQ: SLXP ... (NASDAQ: VVUS ), and Akorn Inc. (NASDAQ: ... accessed at http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets declined ...
(Date:3/26/2015)... , Kalifornien, 26. März 2015 /PRNewswire/ ... Cellworld 2015, die sich speziell an Innovatoren, ... an. Die zweitägige Konferenz für ... September 2015 im Hyatt Regency in ... In diesem Forum werden führende Akteure der ...
(Date:3/26/2015)... 26 de março de 2015 A Finesse ... é projetado especificamente para os inovadores, visionários e executivos ... dias, apenas por convite, será realizada no Hyatt Regency ... 21 e 22 de setembro de 2015. Será um ... o futuro da fabricação de produtos biofarmacêuticos de uso ...
Breaking Medicine Technology:Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5Finesse Solutions kündigt Cellworld 2015 an 2Finesse Solutions anuncia Cellworld 2015 2
... Biopharmaceutical Services, Inc. announced today that the U.S. ... for an Electronic Submissions Gateway (ESG) to the ... clients a validated, direct electronic path for IND ... BLA (Biologic License Application) submissions and builds upon ...
... Gamma Knife® Perfexion™ earned the number one ranking in the ... in KLAS Awards: Medical Equipment & Infrastructure* report. Perfexion ... In the report, Perfexion scored 92.9 out of ... again. On a 1 to 9 scale, Perfexion received an ...
Cached Medicine Technology:Laureate's Electronic Submission Gateway Approved 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 3
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
(Date:3/26/2015)... March 26, 2015 Behavioral Research ... firm, announced the release of BathroomMap® , a ... increase access to public restrooms for travelers, especially those ... apps, BathroomMap does not facilitate a paid, social or ... identify and rate local establishments that have clean, available ...
(Date:3/26/2015)... March 26, 2015 Saving Moses is ... it is most needed but least available. As one ... to six clinics in the Benguela province of Angola ... During a recent visit to their clinics, staff employed ... mothers and their babies in a nation the The ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... 30th “Introduction to Hyperbaric Medicine” course, which is ... Society (UHMS) and the National Board of Diving ... the 40-hour course 4 times a year at ... the NY tri-state region; registration is available on-line ...
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... Getting details in writing would be ideal, survey finds , ... how long it takes to receive the results of radiology ... they do get the results, a U.S. study has found. ... X-ray. , "Most of the patients in our study were ...
... A patient,s socioeconomic status (income, martial status and race) ... radiation therapy for the treatment of prostate cancer, according ... Detroit. "This study offers an extremely ... receive radiation therapy," says Benjamin Movsas, M.D., senior study ...
... of Allergy and Infectious Diseases (NIAID), part of the ... to two programs that support research to better understand ... diseases, including those that may be introduced into a ... awarded to the Cooperative Centers for Translational Research on ...
... the H1N1 pandemic and West Nile virus -- as ... and environmental changes -- has prompted experts to look ... human, and environmental health. In turn, the nonprofit ... for improved collaboration across human, animal, and ecosystem health ...
... drowsy motorists, survey suggests , WEDNESDAY, Nov. 4 (HealthDay News) ... -- have had accidents or near-misses over the past year ... , Also, more than half of drivers surveyed admitted ... and 28 percent said they drive while sleepy at least ...
... , ... Future-focused performance management system prepares hospital leaders for the changing health care environment. ... ... extreme financial challenges—payment reform, reimbursement changes and a shift of patient services to ...
Cached Medicine News:Health News:Waiting, Wondering About Radiology Results Irks Patients 2Health News:Does race, income predict prostate cancer outcome? 2Health News:NIAID announces new human immunology research awards to help fight emerging infectious diseases 2Health News:NIAID announces new human immunology research awards to help fight emerging infectious diseases 3Health News:Sleepy Drivers a Menace on the Road 2Health News:Sg2 Announces Its INSIGHT System to Improve Hospitals' Clinical Performance and Bottom Line Results 2Health News:Sg2 Announces Its INSIGHT System to Improve Hospitals' Clinical Performance and Bottom Line Results 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: